Low dose oral haloperidol does not prolong QTc interval in older acutely hospitalised adults: a subanalysis of a randomised double-blind placebo-controlled study

BACKGROUND: Haloperidol is the most frequently prescribed antipsychotic for delirium symptoms. The risk of QTc prolongation often raises concerns, although the effect of haloperidol on QTc interval has not yet been investigated in a randomised placebo-controlled fixed-dose study. METHODS: A subanaly...

Descripción completa

Detalles Bibliográficos
Autores principales: Schrijver, Edmée JM, Verstraaten, Maaike, van de Ven, Peter M, Bet, Pierre M, van Strien, Astrid M, de Cock, Carel, Nanayakkara, Prabath WB
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087514/
https://www.ncbi.nlm.nih.gov/pubmed/30108611
http://dx.doi.org/10.11909/j.issn.1671-5411.2018.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087514/
https://www.ncbi.nlm.nih.gov/pubmed/30108611
http://dx.doi.org/10.11909/j.issn.1671-5411.2018.06.003

Ejemplares similares